amino acid · for afternoon energy crash
L-Carnitine
Helps brain cells make energy and supports the messenger behind alertness.
Say that in clinical terms
Supports mitochondrial energy production in neurons. Enhances acetylcholine synthesis and reduces oxidative stress.
How strong is the research?
Mixed evidence
A Cochrane review of 2 small trials found very weak evidence and no benefit for memory or attention.
Studied in a narrower group
2 papers read, 1 supporting, 1 against.
Who was studied: The cited paper is from a breast cancer journal and has nothing to do with this.
How much to take
morning
500–1000 mg
Acetyl-L-carnitine crosses BBB more readily. Take early to avoid evening alertness.
Before you take it
- No NIH ODS Tolerable Upper Intake Level (UL) has been established for L-carnitine; long-term safety data at doses above 2g/day are limited.
- GI adverse effects at doses ≥3g/day: nausea, vomiting, abdominal cramps, diarrhea, and fishy body odor; effects are dose-dependent and related to TMAO production.
- TMAO cardiovascular risk: L-carnitine is converted by gut microbiota to trimethylamine (TMA), then by hepatic flavin monooxygenases to trimethylamine-N-oxide (TMAO); elevated TMAO is associated with accelerated atherosclerosis in animal models and with increased major adverse cardiovascular event risk in humans with concurrently high TMAO levels (Koeth et al. 2013, Nature Medicine; acknowledged by NIH ODS fact sheet); omnivores produce substantially more TMAO from the same L-carnitine dose than vegans or vegetarians.
- Warfarin/oral anticoagulant interaction: a single case report documents INR elevation from stable range (1.99–2.94) to 4.65 after a patient with a mechanical aortic valve added L-carnitine to stable warfarin therapy; no RCT evidence confirms this interaction; INR monitoring is prudent if co-administering; evidence quality is case-report only.
- Pivalate-conjugated antibiotics (pivampicillin, pivmecillinam): chronic co-administration may deplete carnitine stores (NIH ODS); this is a carnitine-depletion interaction, not a chelation/timing interaction.
- Anticonvulsants (valproic acid, phenobarbital, phenytoin, carbamazepine): chronic use may reduce carnitine levels; supplemental carnitine may be indicated but should be discussed with prescriber (NIH ODS).
- ALCAR (acetyl-L-carnitine) crosses the blood-brain barrier and has documented neurological pharmacology; L-carnitine (the recommended supplement) does not cross the BBB at physiological doses; conflating the two forms for cognitive or neuronal energy support claims is pharmacologically inaccurate and may mislead users
What we make of it
The citation belongs to an oncology journal.
The detail
The identifier resolves to Breast Cancer Research and Treatment. It has nothing to do with carnitine, energy or afternoon fatigue.